Vasoactive Intestinal Peptide Causes Nitric Oxide-Dependent Pulmonary Vasodilation in Isolated Rat Lung

Respiration

Volumn 64, Issue 1, 1997, Pages 54-58

  Iwabuchi, Satoru ^a   Ono, Sadafumi ^a   Tanita, Tatsuo ^a   Koike, Kaoru ^b   Fujimura, Shigefumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b Miyagi Cancer Center   (Japan)

Author keywords

Angiotensin II; Isolated perfused rat lung; L N nitro arginine; Meclofenamate; Vasoactive intestinal peptide

Indexed keywords

ARGININE; MECLOFENAMIC ACID; NITRIC OXIDE; POTASSIUM CHLORIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LUNG ARTERY PRESSURE; LUNG CIRCULATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ANGIOTENSIN II; ANIMALS; ENZYME INHIBITORS; LUNG; MALE; MECLOFENAMIC ACID; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PERFUSION; PULMONARY CIRCULATION; RATS; RATS, INBRED BUF; VASOACTIVE INTESTINAL PEPTIDE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0031027346     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000196643     Document Type: Article

References (21)

1. Matsuzaki Y, Hamasaki Y, Said SI: Vasoactive intestinal peptide: A possible transmitter of nonadrcnergic relaxation of guinc pig airways, Science 1980:210:1252-1253.
2. Allen K, Wharton J, Polak JM, 1 laworth SG: A study of nerves containing peptides in the pulmonary vasculature of healthy infants and children and of those with pulmonary hypertension, Br Heart J 1989:62:353-360.
3. Barnes PJ, Cadieux A, Carstairs JR, Greenberg B, Polak JM, Rhoden K: Vasoactive intestinal peptide in bovine pulmonary artery: Localization, function and receptor autoradiography, Br J Pharmacol 1986:89:157-162.
4. Carstairs JR, Barnes PJ: Visualization of vasoactive intestinal peptide receptor in human and guinea pig lung, J Pharmacol Exp Thcr 1986:239:249-255.
5. Hamasaki Y, Mojarad M, Said SI: Relaxant action of VIP on cat pulmonary artery: Comparison with acetylcholine, isoproterenol, and PGE,. J Appl Physiol 1983;54:1607-1611.
6. Altiere R, Diamond L: Relaxant effects of vasoactive intestinal peptide and bethanechol in cat intrapulmonary artery, Eur J Pharmacol 1983:93:121-124.
7. Sata T, Misra HP, Kubota E, Said Si: Vasoactive intestinal polypeptide relaxes pulmonary artery by an endothelium-independent mechanism, Peptide 1986:7(suppl):225-227.
8. Greenberg B, Rhoden K, Barnes PJ: Relaxant effects of vasoactive intestinal peptide and peptide histidine isoleucine in human and bovine pulmonarv arteries, Blood Vessels 1987:24:45- 50.
9. Ono S, Westcott JY, Voclkel NF: PAF antagonists inhibit pulmonary vascular remodeling induced by hvpobaric hypoxia in rats, J Appl Physiol 1992:73:1084-1092.
10. Moor PK, al-Swayeh OA, Chong NWS, Evans RA, Gibson A: Z.-N°-nitro-arginine (/.-NOARG), a novel, /.-arginine reversible inhibitor of endothelium-dependent vasodilation in vivo, Br J Pharmacol 1990:99:408-412.
11. Toda N, Okamura T: Possible role of nitric oxide in transmitting information from vasodilator nerve to cerebroarlerial muscle, Biochem Biophys Res Commun 1990; 170:308-313.
12. Palmer RMJ, Rees DD, Ashton DS, Moncada S: /--Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation, Biochem Biophys Res Commun 1988:153:1251-1256.
13. Nandiwada PA, Kadowitz PJ, Said SI, Mojarad M, Hyman AL: Pulmonary vasodilator responses to vasoactive intestinal peptide in the cat, J Appl Physiol 1985:58:1723-1728.
14. Minkes RK, McMahon TJ, Hood JS, Murphy WA, Coy DH, McNamara DB, Kadowitz PJ: Differential effects of PACAP and VIP on the pulmonary and hindquarters vascular beds of the cat, J Appl Physiol 1992:72:1212-1217.
15. Nagasaka Y, Bhattaeharya J, Nanjo S, Gropper MA, Staub NC: Micropuncturc measurement of lung microvascular pressure profile during hypoxia in cats, Circ Res 1984:54:90-95.
16. Furchgott RF: Role of endothelium in responses of vascular smooth muscle, Circ Res 1983:53:557-573.
17. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology, Pharmacol Rev 1991:43:109-142.
18. Ishii K, Chang B, Kerwin JF, Huang ZJ, Murad F: N"-n it ro-/.-arginine: A potent inhibit of endothelium-derived relaxing factor formation, Eur J Pharmacol 1990:176:219-223.
19. Kobzik L, Bredt DS, Lowenstein CJ, Drazcn J, Gaston B, Sugarbakcr D, Stamler JS: Nitric oxide synthase in human and rat lung: Immu-nocvtochemical and histochemical localization, Am J Respir Cell Mol Biol 1993:9:371-377.
20. Li CG, Rand MJ: Evidence that part of the relaxant response of guinea-pig trachea to electrical field stimulation is mediated by nitric oxide, J Pharmacol 1991;102:91-94.
21. Voclkel NF, Gerber JG, McMurtry IF, Nies AS, Reeves JT: Release of vasodilator prostaglandin, PGH, from isolated rat lung during vasoconstriction, Circ Res 1981 -.48:207-213.